According to CD21 and CD23 staining, TLSs in a tumor were classified into three developmental stages: early (CD21-CD23-), primary (CD21 + CD23-), and secondary (CD21 + CD23+) stages [28]. This evidence concerns the gene FCER2 and neoplasm.